These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6316036)

  • 21. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.
    Anderson GD; Chan LN
    Clin Pharmacokinet; 2016 Nov; 55(11):1353-1368. PubMed ID: 27106177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marijuana effects on associations to novel stimuli.
    Tinklenberg JR; Darley CF; Roth WT; Pfefferbaum A; Kopell BS
    J Nerv Ment Dis; 1978 May; 166(5):362-4. PubMed ID: 650201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marijuana, tetrahydrocannabinol, and pulmonary antibacterial defenses.
    Huber GL; Pochay VE; Pereira W; Shea JW; Hinds WC; First MW; Sornberger GC
    Chest; 1980 Mar; 77(3):403-10. PubMed ID: 6244135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.
    Cooler P; Gregg JM
    South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of marijuana on human reaction time and motor control.
    Kvålseth TO
    Percept Mot Skills; 1977 Dec; 45(3 Pt 1):935-9. PubMed ID: 600655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoids inhibit testosterone secretion by mouse testes in vitro.
    Dalterio S; Bartke A; Burstein S
    Science; 1977 Jun; 196(4297):1472-3. PubMed ID: 867048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marijuana effects on long-term memory assessment and retrieval.
    Darley CF; Tinklenberg JR; Roth WT; Vernon S; Kopell BS
    Psychopharmacology (Berl); 1977 May; 52(3):239-41. PubMed ID: 406626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preference for high- versus low-potency marijuana.
    Chait LD; Burke KA
    Pharmacol Biochem Behav; 1994 Nov; 49(3):643-7. PubMed ID: 7862719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
    Cone EJ; Johnson RE
    Clin Pharmacol Ther; 1986 Sep; 40(3):247-56. PubMed ID: 3017628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
    Ohlsson A; Lindgren JE; Wahlen A; Agurell S; Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1980 Sep; 28(3):409-16. PubMed ID: 6250760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta9-tetrahydrocannabinol increase plasma testosterone concentrations in mice.
    Dalterio S; Bartke A; Mayfield D
    Science; 1981 Jul; 213(4507):581-3. PubMed ID: 6264607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-pressure liquid chromatographic--mass spectrometric determination of delta9-tetrahydrocannabinol in human plasma following marijuana smoking.
    Valentine JL; Bryant PJ; Gutshall PL; Gan OH; Lovegreen PD; Thompson ED; Niu HC
    J Pharm Sci; 1977 Sep; 66(9):1263-6. PubMed ID: 903863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical marijuana and dronabinol.
    PI Perspect; 1996 Nov; (No 20):20. PubMed ID: 11363969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Δ(9)-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake - A pilot study using illicit cannabis.
    Coucke L; Massarini E; Ostijn Z; Beck O; Verstraete AG
    Clin Biochem; 2016 Sep; 49(13-14):1072-7. PubMed ID: 27288550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marijuana's acute effects on cognitive bias for affective and marijuana cues.
    Metrik J; Aston ER; Kahler CW; Rohsenow DJ; McGeary JE; Knopik VS
    Exp Clin Psychopharmacol; 2015 Oct; 23(5):339-50. PubMed ID: 26167716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic study of smoking marijuana.
    Barnett G; Chiang CW; Perez-Reyes M; Owens SM
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):495-506. PubMed ID: 6300367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.
    Ohlsson A; Lindgren JE; Wahlén A; Agurell S; Hollister LE; Gillespie HK
    Biomed Mass Spectrom; 1982 Jan; 9(1):6-10. PubMed ID: 6277407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.